The American Journal of Medicine
Volume 123, Issue 6 , Pages 536-541, June 2010

Adherence to Pharmacological Thromboprophylaxis Orders in Hospitalized Patients

  • John Fanikos, RPh, MBA

      Affiliations

    • Department of Pharmacy, Brigham and Women's Hospital, Boston, Mass
    • ,
  • Leslie Ann Stevens, BS

      Affiliations

    • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Matthew Labreche

      Affiliations

    • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Gregory Piazza, MD

      Affiliations

    • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass
    • ,
  • Elaine Catapane, MEd, MT (ASCP)

      Affiliations

    • Harvard Clinical Research Institute, Harvard Medical School, Boston, Mass
    • ,
  • Lena Novack, PhD

      Affiliations

    • Harvard Clinical Research Institute, Harvard Medical School, Boston, Mass
    • ,
  • Samuel Z. Goldhaber, MD

      Affiliations

    • Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass
    • Corresponding Author InformationRequests for reprints should be addressed to Samuel Z. Goldhaber, MD, Cardiovascular Division, Brigham and Women's Hospital, 75 Francis Street, Boston, MA 02115

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Funding: Sanofi-aventis.

 Conflict of Interest: John Fanikos, RPh, MBA serves on the Speakers Bureau for sanofi-aventis and GlaxoSmithKline and has served as a consultant/advisory board participant. Samuel Z. Goldhaber, MD, receives research funds and is a consultant for sanofi-aventis, Eisai, Bristol-Myers Squibb, and Boehringer-Ingelheim. The remaining authors have no conflicts to disclose.

 Authorship: All authors had access to the data and participated in the manuscript preparation.

PII: S0002-9343(10)00066-5

doi:10.1016/j.amjmed.2009.11.017

The American Journal of Medicine
Volume 123, Issue 6 , Pages 536-541, June 2010

Article Tools

* Image Usage & Resolution